Group 1 - The core point of the article highlights that southbound funds increased their holdings in Jinxin Reproductive Medicine (01951.HK) by 2.727 million shares on February 13, 2026, while experiencing a net reduction of 13.909 million shares over the past five trading days [1] - Over the last 20 trading days, southbound funds have increased their holdings in Jinxin Reproductive Medicine on 15 occasions, resulting in a total net increase of 24.1786 million shares [1] - As of now, southbound funds hold 1.461 billion shares of Jinxin Reproductive Medicine, accounting for 52.97% of the company's total issued ordinary shares [1] Group 2 - Jinxin Reproductive Medicine Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [2] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facilities, auxiliary medical services, obstetrics and pediatrics medical services, as well as the sale of medical consumables and equipment [2] - The company's services are mainly provided in China and the United States [2]
锦欣生殖（01951.HK）：2月13日南向资金增持272.7万股